Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPACK Block Efficacy in Total Knee Arthroplasty
NCT03692858Phase 2Unknown
- Sponsor
- Asklepieion Voulas General Hospital
- Start
- Oct 2018
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Asklepieion Voulas General Hospital. Primary endpoints: Numeric Rating Scale scores at 48 hours, Morphine consumption at 24 hours and 1 more. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03692858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03692858.